Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial

International Journal of Stroke

Volumn 9, Issue A100, 2014, Pages 43-47

  Estol, Conrado J ^a   Bath, Philip M W ^b   Gorelick, Philip B ^b   Martin, Renee Hebert ^b   Diener, H C ^b   Bath, P ^b   Donnan, G A ^b   Cotton, D ^b   Estol, C ^b   Hilbrich, L ^b   Humphreys, M ^b   Ounpuu S ^b   Roberts, R ^b   Teal, P ^b   Toni, D ^b   Sacco, R ^b   Yusuf, S ^b  

^a Neurological and Vascular Prevention Unit   (Argentina)

^b NONE

Author keywords

Cerebrovascular disease; Race ethnicity; Stroke; Vascular recurrence

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; PLACEBO; TELMISARTAN; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE;

ADULT; AFRICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BLACK PERSON; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUCASIAN; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; ETHNIC DIFFERENCE; EUROPEAN; FACTORIAL DESIGN; FEMALE; FOLLOW UP; HEART INFARCTION; HEMORRHAGE FREE SURVIVAL; HISPANIC; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; SECONDARY PREVENTION; STATISTICAL ANALYSIS; STROKE FREE SURVIVAL; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; ETHICS; ETHNIC GROUP; ETHNOLOGY; INTRACRANIAL HEMORRHAGES; ISCHEMIA; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; STROKE;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; ETHNIC GROUPS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; ISCHEMIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SECONDARY PREVENTION; STROKE;

EID: 84911947561     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12269     Document Type: Article

References (21)

1. Sacco RL, Diener HC, Yusuf S etal. Aspirin and extended release dipyridamole versus clopidogrel for recurrent stroke. New Engl J Med 2008; 359:1238-1251.
2. Sacco RL, Boden-Albala B, Abel G etal. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke 2001; 32:1725-1731.
3. Mc Gruder HF, Malarcher AM, Antoine TL, Greenlund KJ, Croft JB. Racial and ethnic disparities in cardiovascular Risk factors among stroke survivors (USA 1999-2001). Stroke 2004; 35:1557-1561.
4. Sacco RL, Kaufman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 1995; 26:14-20.
5. Feldmann E, Daneault N, Kwan E etal. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541-1545.
6. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17:648-655.
7. Inzitari D, Hachinski VC, Taylor W, Barnett HJM. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factors? Arch Neurol 1990; 47:1080-1084.
8. Waddy SP, Cotsonis G, Lynn MJ etal. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke 2009; 40:719-725.
9. Diener HC, Sacco R, Yusuf S. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007; 23:368-380.
10. Yusuf S, Diener HC, Sacco RL etal. Telmisartan to prevent recurrent stroke and cardiovascular events. New Engl J Med 2009; 359:1225-1237.
11. Estol CJ, Bath PM, Gorelick PB, Cotton D, Martin RH, Weber MA. Blood pressure control variations among different race-ethnic groups in the PRoFESS Study. Blood Press Monit 2014 (in press).
12. Wong KS, Haung YN, Gao S, Lam WWM, Chan YL. Cerebrovascular disease among Chinese populations - recent epidemiological and neuroimaging studies. Hong Kong Med J 2001; 7:50-57.
13. Morikawa Y, Nakagawa H, Naruse Y etal. Trends in stroke incidence and acute case fatality in a Japanese rural area - the oyabe study. Stroke 2000; 31:1583-1587.
14. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stroke 1992; 23:1237-1241.
15. Cheng XM, Ziegler DK, Lai YH. Stroke in China, 1986 through 1990. Stroke 1995; 26:1990-1994.
16. Nguyen-Huynh MN, Johnston SC. Regional variation in hospitalization for stroke among Asians/Pacific Islanders in the United States: a nationwide retrospective cohort study. BMC Neurol 2005; 5:21.
17. Nogales-Gaete J, Núñez L, Arriagada C etal. Caracterización clínica de 450 pacientes con enfermedad cerebrovascular ingresados a un hospital público durante 1997. Rev Med Chil 2000; 128:1227-1236.
18. Del Brutto OH, Mosquera A, Sánchez X, Santos J, Noboa CA. Stroke subtypes among hispanics living in Guayaquil, Ecuador: results from the Luis Vernaza Hospital stroke registry. Stroke 1993; 24:1833-1836.
19. Estol CJ, Esnaola MM. Stroke in Argentina. Int J Stroke 2010; 5:35-39.
20. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008; 39:2396-2399.
21. Ovbiagele B, Diener HC, Yusuf S etal. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011; 306:2137-2144.